Brief: Avecho Biotechnology Receives Ethics Approval For CBD Human Trial
April 13 (Reuters) - Avecho Biotechnology Ltd AVE.AX :
* AVECHO RECEIVES ETHICS APPROVAL FOR CBD HUMAN TRIAL
* HAS COMMENCED PLANNING FOR CBD DEVELOPMENT PROGRAM BEYOND
PHASE
I, WITH A FOCUS ON TGA REGISTRATION
Source text for Eikon: ID:nASX2HZF3d
Further company coverage: AVE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avecho Biotechnology
See all newsBrief: Avecho Biotechnology Seeks Trading Halt
Australia's Avecho Biotechnology falls on discounted placement
Brief: Avecho Biotechnology Raises A$2.5M Via Placement
Brief: Avecho And Sandoz Enter Exclusive License And Development Agreement
Brief: Avecho Biotechnology Seeks Trading Halt Pending Release Of Information About License And Development Agreement